Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

XRTX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

XRTX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

XORTX Therapeutics Inc.(XRTX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

XORTX Therapeutics Inc.(XRTX US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income StatementBalance Sheet

Cash Flow

Millions CAD (ex. Per Share)
FY201402/28/2015
FY201502/29/2016
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-3.1-4.5-3.9-3.9
Depreciation & Amortization0.20.20.20.2
Stock Based Compensation0.2-0.00.0
Change in Working Capital-1.50.20.50.5
Other Non-Cash Items-5.2-0.8-0.8-0.5
Net Cash from Operating Activities-9.4-5.0-4.0-3.7
-Investments in Property, Plant & Equipment-0.0-0.1-0.1-0.1
-Acquisitions Net----
-Purchases of Investments----
Sales/Maturities of Investments----
Other Investing Activities-0.1--0.3-0.4
Net Cash from Investing Activities-0.1-0.1-0.4-0.4
Net Debt Issuance-0.1-0.1--0.0
Net Stock Issuance-3.92.21.9
-Net Dividends Paid----
Other Financing Activities-0.6-0.0-0.1-0.1
Net Cash from Financing Activities-0.73.82.11.8
Effect of Forex Changes0.00.3-0.1-0.0
Net Change in Cash-10.0-1.0-2.5-2.4
Cash at End of Period4.92.51.24.8
Operating Cash Flow-9.4-5.0-4.0-3.7
-Capital Expenditure-0.1-0.0-0.10.6
Free Cash Flow-9.5-5.0-4.0-3.8

Financials

Income StatementBalance Sheet

Cash Flow

Millions CAD (ex. Per Share)
FY201402/28/2015
FY201502/29/2016
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-3.1-4.5-3.9-3.9
Depreciation & Amortization0.20.20.20.2
Stock Based Compensation0.2-0.00.0
Change in Working Capital-1.50.20.50.5
Other Non-Cash Items-5.2-0.8-0.8-0.5
Net Cash from Operating Activities-9.4-5.0-4.0-3.7
-Investments in Property, Plant & Equipment-0.0-0.1-0.1-0.1
-Acquisitions Net----
-Purchases of Investments----
Sales/Maturities of Investments----
Other Investing Activities-0.1--0.3-0.4
Net Cash from Investing Activities-0.1-0.1-0.4-0.4
Net Debt Issuance-0.1-0.1--0.0
Net Stock Issuance-3.92.21.9
-Net Dividends Paid----
Other Financing Activities-0.6-0.0-0.1-0.1
Net Cash from Financing Activities-0.73.82.11.8
Effect of Forex Changes0.00.3-0.1-0.0
Net Change in Cash-10.0-1.0-2.5-2.4
Cash at End of Period4.92.51.24.8
Operating Cash Flow-9.4-5.0-4.0-3.7
-Capital Expenditure-0.1-0.0-0.10.6
Free Cash Flow-9.5-5.0-4.0-3.8